Effect of Coating of Emdogain on Dental Implants

Comparative Evaluation of Crestal bone loss around Dental Implants coated with and without Enamel Matrix Protein Derivative(Emdogain): A clinico-radiographic CBCT study - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/10/076078

Enrollment

Registered

2024-10-30

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K069- Disorder of gingiva and edentulousalveolar ridge, unspecified Health Condition 2: K068- Other specified disorders of gingiva and edentulous alveolar ridge Health Condition 3: K068- Other specified disorders of gingiva and edentulous alveolar ridge

Interventions

Intervention1: Dental Implants coated with Emdogain: Ten patients with edentulous site requiring installation of dental implants with Emdogain were selected, for a total duration of 2 years. Enamel ma

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having single missing tooth with an adequate width and height of edentulous space available for placement of implant. 2.Edentulous sites in mandibular and maxillary arches. 3.Adjacent teeth intact; restored with functionally & aesthetically good restorations; restored with prosthesis precluding the addition of the missing tooth. 4.Patients with good periodontal and general health.

Exclusion criteria

Exclusion criteria: 1.Patients who are unable to perform routine oral hygiene procedures. 2.Patients with history of smoking. 3.Patients with TMJ disorders. 4.Patients with dental history of bruxism and parafunctional habits or deep bite cases. 5.History of substance abuse. 6.Insufficient vertical inter-arch spaces to accommodate the prosthodontic components available, together with a proposed pontic and occasional gingival analogue designs. 7.Patients with uncontrolled diabetes. 8.Absence of opposing occlusion.

Design outcomes

Secondary

Measure	Time frame
Peri-Implant Soft Tissue Health Around Dental Implants Through Keratinized Mucosa Index And Probing DepthTimepoint: 3 And 9 Months After Implant Placement	—

Primary

Measure	Time frame
Crestal Bone Loss Around Dental Implants Evaluated Through Clinico-Cbct Radiographic StudyTimepoint: 9 Months After Implant Placement	—

Countries

India

Contacts

Public ContactMegha Joshi

Subharti Dental College Swami Vivekanand Subharti university

drmayurkaushik@gmail.com9759444434

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026